Theorizing the Bioeconomy: Biovalue, Biocapital, Bioeconomics or ... What?
Theorizing the Bioeconomy: Biovalue, Biocapital, Bioeconomics or ... What?
复制标题
DOI：
10.1177/0162243912442398
复制
发表时间：
2013-05-01
影响因子：
3.1
通讯作者：
Tyfield, David
中科院分区：
文献类型：
--
作者：
Birch, Kean;Tyfield, David
在经济合作与发展组织 (OECD) 和欧盟委员会 (EC) 的政策论述中，现代生物技术和生命科学被描述为新兴的“生物经济”，其中生物材料和产品的潜在价值为可持续经济增长提供了机会。现代生物技术和经济发展的这种阐述是一个新兴的学术领域，产生了大量的“生物概念”。在过去十年左右的时间里，人们进行了许多尝试来理论化两者之间的关系。生物技术及其资本化。本文强调了这些概念中的一些潜在的模糊性，尤其是对“生物”一切事物的迷恋。我们通过重新思考几个关键经济和金融过程的理论重要性，提供了生物经济的另一种观点。
In the policy discourses of the Organization for Economic Cooperation and Development (OECD) and European Commission (EC), modern biotechnology and the life sciences are represented as an emerging "bioeconomy'' in which the latent value underpinning biological materials and products offers the opportunity for sustainable economic growth. This articulation of modern biotechnology and economic development is an emerging scholarly field producing numerous "bio-concepts.'' Over the last decade or so, there have been a number of attempts to theorize this relationship between biotechnologies and their capitalization. This article highlights some of the underlying ambiguities in these conceptualizations, especially in the fetishization of everything "bio.'' We offer an alternative view of the bioeconomy by rethinking the theoretical importance of several key economic and financial processes.